2012
DOI: 10.1038/bjc.2012.347
|View full text |Cite
|
Sign up to set email alerts
|

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer

Abstract: Background:The importance of the components of host local inflammatory response in determining outcome in primary operable ductal invasive breast cancer is not clear. The aim of this study was to examine the relationship between components of the tumour inflammatory cell infiltrate and standard clinicopathological factors including hormone status (oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER)-2), Ki-67 and survival in patients with primary operable invasiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
104
1
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 127 publications
(115 citation statements)
references
References 26 publications
9
104
1
1
Order By: Relevance
“…Slides were histopathologically analysed for (i) TILs (defined as the mean percentage of stroma of invasive carcinoma infiltrated by lymphocytes and plasma cells in 10% increments; if <10% of stroma was infiltrated by TILs, 1% or 5% criteria were used; all available full sections were evaluated);1 19 (ii) the amount of inflammatory cells evaluated at the tumour's invasive margin (according to Klintrup criteria; score 0, no inflammatory cells at the invasive margin; score 1, mild and patchy increase of inflammatory cells; score 2, increased inflammatory cells forming a band-like infiltration at the invasive margin; score 3, prominent inflammatory reaction forming a cup-like zone at the invasive margin);6 20 (iii) aggregation of lymphoid cells in terminal duct lobular units (TDLUs; within 5 mm and >5 mm from the invasive or in situ carcinoma); (iv) the amount of TLSs in adjacent tissue including the in situ component (none, no TLS formation in the area adjacent to the tumour; little, TLSs occupying an area of <10% of the circumference of the tumour; moderate, 10–50%; or abundant, >50%; shown in figure 1); (v) the presence or absence of a germinal centre in TLSs; (vi) the percentage of tumour stroma in the most invasive tumour area (high percentage of tumour stroma, >50%; low percentage of tumour stroma, ≤50%);16 (vii) heterogeneity of the tumour (heterogeneous: invasive tumour mixed with normal breast parenchyma; homogeneous: invasive tumour mass without normal breast parenchyma); (viii) histological subtype and grade, percentage of in situ component, tumour size, pT stage, pN stage and lymphovascular invasion. Lymphoid aggregation with vessels showing HEV features (plump, cuboidal endothelial cells) with or without germinal centres was considered a TLS.…”
Section: Patients Materials and Methodsmentioning
confidence: 99%
“…Slides were histopathologically analysed for (i) TILs (defined as the mean percentage of stroma of invasive carcinoma infiltrated by lymphocytes and plasma cells in 10% increments; if <10% of stroma was infiltrated by TILs, 1% or 5% criteria were used; all available full sections were evaluated);1 19 (ii) the amount of inflammatory cells evaluated at the tumour's invasive margin (according to Klintrup criteria; score 0, no inflammatory cells at the invasive margin; score 1, mild and patchy increase of inflammatory cells; score 2, increased inflammatory cells forming a band-like infiltration at the invasive margin; score 3, prominent inflammatory reaction forming a cup-like zone at the invasive margin);6 20 (iii) aggregation of lymphoid cells in terminal duct lobular units (TDLUs; within 5 mm and >5 mm from the invasive or in situ carcinoma); (iv) the amount of TLSs in adjacent tissue including the in situ component (none, no TLS formation in the area adjacent to the tumour; little, TLSs occupying an area of <10% of the circumference of the tumour; moderate, 10–50%; or abundant, >50%; shown in figure 1); (v) the presence or absence of a germinal centre in TLSs; (vi) the percentage of tumour stroma in the most invasive tumour area (high percentage of tumour stroma, >50%; low percentage of tumour stroma, ≤50%);16 (vii) heterogeneity of the tumour (heterogeneous: invasive tumour mixed with normal breast parenchyma; homogeneous: invasive tumour mass without normal breast parenchyma); (viii) histological subtype and grade, percentage of in situ component, tumour size, pT stage, pN stage and lymphovascular invasion. Lymphoid aggregation with vessels showing HEV features (plump, cuboidal endothelial cells) with or without germinal centres was considered a TLS.…”
Section: Patients Materials and Methodsmentioning
confidence: 99%
“…Some data suggest thathighlevelsofTILsarealsoassociatedwithbetteroutcomesinHER2-positivebreastcancerpatients treatedwithtrastuzumabaswellasdualtrastuzumab and lapatinib with chemotherapy [7,11]. These findingsweresupportedbythelargephaseIIIBIG 02-98trial.ApositiveassociationbetweenTILsand survival independent of clinicopathological characteristics in primary operable ductal invasive breast cancerwasdescribedbyMohammedet al [16].High levels of TILs correlate with increased disease-free survival (DFS) after adjuvant anthracycline-based chemotherapy [13].IntheECOGtrials(E2197and E1199)multivariableanalysisconfirmedTILstobe an independent prognostic marker of DFS, DRFI (distantrecurrence-freeinterval)andOS(overallsurvival) for TNBCs. In this group higher TIL scores wereassociatedwithbetterprognosis;forevery10% increase in TILs, a 14% reduction of risk of recurrenceordeath(p =0.02),an18%reductionofrisk ofdistantrecurrence(p =0.04),anda19%reduction ofriskofdeath(p =0.01)weredescribed [19].As fornow,thestrongestassociationofTILsandbreast cancer outcome has been observed for TNBC patients who received adjuvant anthracycline-containing chemotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…In previous analysis general inflammatory cellinfiltrationwasassociatedwithhighgrade,negativesteroid(ERandPR)receptorstatusandthepresenceofvascularinvasion [16].AhigherlevelofTILs wasdescribedinbreastcancerwithhigherdifferentiation,negativehormonereceptorstatusandHER2 overexpression [7]. An association between BRCA1 mutation and TILs was detected in ovarian cancer [17].Theauthorsdidnotfindsuchanassociationfor breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the presence of TILs can influence the prognosis of BC patients. In this regard, large series of data suggest that tumors with higher TIL counts are associated with good prognosis in contrast with those with lower TILs [13][14][15]. However, in single studies, the prognostic effect was mostly robust in triple-negative BC (TNBC) and less well-established in other subtypes [16][17][18][19].…”
Section: Introductionmentioning
confidence: 99%